Header Logo

Connection

SHERISE DESIREE FERGUSON to Antibodies, Monoclonal, Humanized

Back to Details
This is a "connection" page, showing publications SHERISE DESIREE FERGUSON has written about Antibodies, Monoclonal, Humanized.
SHERISE DESIREE FERGUSON
Connection Strength
0.020
Antibodies, Monoclonal, Humanized
  1. Window-of-opportunity clinical trial of pembrolizumab in patients with recurrent glioblastoma reveals predominance of immune-suppressive macrophages. Neuro Oncol. 2020 04 15; 22(4):539-549.
    View in: PubMed
    Score: 0.020
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.